This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Wright Medical Group, Inc. Prices $260 Million Cash Convertible Senior Notes Offering

Stocks in this article: WMGI

Wright Medical Group, Inc. (NASDAQ: WMGI) (the “Company”) today announced the pricing of its offering (the “Offering”) of $260 million principal amount of cash convertible senior notes due 2017 (the “Notes”). The Notes are being offered and sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The Company also granted the initial purchasers of the Notes an option to purchase up to an additional $40 million principal amount of Notes to cover over-allotments. The Offering is expected to close on August 31, 2012, subject to customary closing conditions.

Interest will be payable on the Notes semi-annually at a rate of 2.00 percent per annum on February 15 and August 15 of each year, beginning February 15, 2013. Prior to February 15, 2017, the Notes will be convertible into cash at the option of the holder under certain conditions and, regardless of any conditions, thereafter until the second scheduled trading day immediately preceding the maturity date . The Notes will mature on August 15, 2017. The initial conversion rate for the Notes is 39.3140 shares of the Company’s common stock per $1,000 principal amount of the Notes, which is equivalent to a conversion price of approximately $25.44 per share of the Company’s common stock, representing an approximately 27.50% conversion premium based on the last reported sale price of the Company’s common stock of $19.95 per share on August 22, 2012.

In connection with the pricing of the Notes, the Company has entered into privately negotiated convertible note hedge transactions with certain financial institutions (the “Option Counterparties”) to reduce its exposure under the Notes to future increases in the price of the Company’s common stock. The Company has also entered into separate privately negotiated warrant transactions with the Option Counterparties, and the warrants have an exercise price that is 50.00% higher than the last reported sale price per share of the Company’s common stock on August 22, 2012. The issuance of the warrants could have a dilutive effect on the Company’s common stock to the extent that the market price of the Company’s common stock exceeds the exercise price of the warrants. If the initial purchasers exercise their over-allotment option, the Company intends to enter into additional convertible note hedge and warrant transactions.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,325.56 -353.14 -2.00%
S&P 500 2,030.90 -26.19 -1.27%
NASDAQ 4,693.6510 -78.1120 -1.64%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs